Related Experiment Video

Updated: Aug 15, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

[Usefulness of Cochrane Collaboration for pediatric cardiology]

Javier González-de Dios1, Albert Balaguer-Santamaría, Carlos Ochoa-Sangrador

  • 1Departamento de Pediatría, Hospital Universitario San Juan, Universidad Miguel Hernández, Alicante, Spain. gonzalez_jav@gva.es

Revista Espanola De Cardiologia
|September 28, 2005
PubMed

Insights

Cochrane systematic reviews in pediatric cardiology are infrequent and often lack sufficient evidence for clinical practice. Many important pediatric heart conditions lack reviews, highlighting a gap in evidence-based care.

Area of Science:

  • Cardiology
  • Evidence-Based Medicine
  • Systematic Reviews

Background:

  • The Cochrane Collaboration provides systematic reviews to support medical decision-making.
  • Systematic reviews are crucial for evidence-based practice in medicine.

Purpose of the Study:

  • To analyze the availability and quality of Cochrane systematic reviews in pediatric cardiology.
  • To identify gaps in evidence-based reviews for pediatric cardiovascular conditions.

Main Methods:

  • Systematic search and analysis of Cochrane Collaboration's systematic reviews.
  • Categorization of reviews by relevant Cochrane Review Groups.
  • Assessment of the scope and focus of pediatric cardiology reviews.

Main Results:

  • Only 20 systematic reviews were identified in pediatric cardiology.
  • Reviews primarily focused on patent ductus arteriosus, hypotension in preterm infants, and Kawasaki disease.
  • Limited quality of clinical trials in some reviews (e.g., rheumatic fever, childhood obesity).
  • No systematic reviews found for critical areas like heart failure, shock, hypertension, congenital heart disease, or arrhythmias.
  • Many pediatric therapies lack supportive evidence.

Conclusions:

  • Systematic reviews in pediatric cardiology are infrequent and often of limited quality or scope.
  • There is a significant lack of evidence-based reviews for major pediatric cardiovascular conditions.
  • Clinical practice in pediatric cardiology often relies on therapies without strong supporting evidence.
  • Further research and systematic reviews are urgently needed for key pediatric cardiology topics.

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...